SARS-CoV-2 Omicron variant

sars-cov-2 variant
The Omicron variant is a variant of SARS-CoV-2 that was first reported to the World Health Organization from South Africa on 24 November 2021. Omicron multiplies around 70 times faster than the Delta variant in the bronchi but evidence suggests it is less severe than previous strains, especially compared to the Delta variant. Omicron might be less able to penetrate deep lung tissue. Omicron infections are 91 percent less fatal than the delta variant, with 51 percent less risk of... The Omicron variant is a variant of SARS-CoV-2 that was first reported to the World Health Organization from South Africa on 24 November 2021. Omicron multiplies around 70 times faster than the Delta variant in the bronchi but evidence suggests it is less severe than previous strains, especially compared to the Delta variant. Omicron might be less able to penetrate deep lung tissue. Omicron infections are 91 percent less fatal than the delta variant, with 51 percent less risk of hospitalization. However, estimated difference in intrinsic hospitalization risk largely decreases to 0-30 percent when reinfections are discounted. Overall, the extremely high rate of spread, combined with its ability to evade both double vaccination and the body's immune system, means the total number of patients requiring hospital care at any given time is still of great concern.
COVID-19 pandemic in Africa - The COVID-19 pandemic was confirmed to have spread to Africa on 14 February 2020, with the first confirmed case announced in Egypt. The first confirmed case in sub-Saharan Africa was announced in Nigeria at the end of February 2020.
COVID-19 vaccination in Africa - COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021.
COVID-19 vaccination in Botswana - COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019, in response to the ongoing pandemic in the country.
COVID-19 vaccination in South Africa - COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019, in response to the ongoing pandemic in the country.
Variants of SARS-CoV-2 - There are many variants of severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019.
Videos from omicron variant
Share Feedback Report